Targeted therapy in prostate cancer--are we our own worst enemy?
Dawson
Nancy A
NA
D000077868:Atrasentan; D019332:Endothelin-1 / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011759:Pyrrolidines / Q000627:therapeutic use*
D019332:Endothelin-1; D011759:Pyrrolidines; D000077868:Atrasentan